Pharmacodynamic markers and clinical results from the phase 2 study of the SMAC mimetic birinapant in women with relapsed platinum-resistant or -refractory epithelial ovarian cancer
Anne M. Noonan, Kristen P. Bunch, Jin Qiu Chen, Michelle A. Herrmann, Jung Min Lee, Elise C. Kohn, Ciara C. O'Sullivan, Elizabeth Jordan, Nicole Houston, Naoko Takebe, Robert J. Kinders, Liang Cao, Cody J. Peer, W. Douglas Figg, Christina M. Annunziata*
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
78Scopus
citations
Fingerprint
Dive into the research topics of 'Pharmacodynamic markers and clinical results from the phase 2 study of the SMAC mimetic birinapant in women with relapsed platinum-resistant or -refractory epithelial ovarian cancer'. Together they form a unique fingerprint.